<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Surgical management of Crohn disease
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Surgical management of Crohn disease
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Surgical management of Crohn disease
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Phillip R Fleshner, MD, FACS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Martin Weiser, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 29, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3870995">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Crohn disease is a chronic, unremitting, incurable inflammatory disorder that can affect any segment of the gastrointestinal tract as well as extraintestinal sites [
         <a href="#rid1">
          1
         </a>
         ]. The mainstay of treatment for Crohn disease is medical. However, one in two patients with Crohn disease can expect to have at least one surgical procedure due to complications or refractory symptoms.
        </p>
        <p>
         The surgical and endoscopic management of Crohn disease of the small bowel, colon, and rectum is discussed in this topic. The clinical manifestations and diagnosis of Crohn disease, medical therapy for patients with Crohn disease, and extraintestinal manifestations of Crohn disease are discussed elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4070.html" rel="external">
          "Clinical manifestations, diagnosis, and prognosis of Crohn disease in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4069.html" rel="external">
          "Overview of the medical management of mild (low risk) Crohn disease in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/16224.html" rel="external">
          "Medical management of moderate to severe Crohn disease in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4082.html" rel="external">
          "Perianal Crohn disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H30924405">
         <span class="h1">
          PREOPERATIVE PREPARATION
         </span>
        </p>
        <p class="headingAnchor" id="H3461279804">
         <span class="h2">
          Medical optimization
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the majority of patients requiring operative intervention for Crohn disease are young, those who present acutely (eg, with sepsis or perforation) can be seriously ill, and those who present with chronic symptoms (eg, with strictures) can be malnourished.
        </p>
        <p>
         Therefore, the patient's medical condition should be optimized by correcting anemia, fluid depletion, electrolyte imbalance, and malnutrition prior to surgery if possible. Although some patients may require total
         <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">
          parenteral nutrition
         </a>
         (TPN) due to prolonged intolerance of oral nutrition, long-term preoperative TPN should be avoided. In patients with fistulizing disease, the use of exclusive enteral nutrition (EEN) has been shown to reduce postoperative septic complications [
         <a href="#rid2">
          2
         </a>
         ]. The use of TPN in surgical patients is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2880.html" rel="external">
          "Overview of perioperative nutrition support"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/104221.html" rel="external">
          "Postoperative parenteral nutrition in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3246744372">
         <span class="h2">
          Immunosuppressive or biologic therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients with Crohn disease who require surgery are on high-dose glucocorticoid, immunomodulator, and/or biologic agents (eg,
         <a class="drug drug_general" data-topicid="8984" href="/z/d/drug information/8984.html" rel="external">
          infliximab
         </a>
         ), which can impact surgical outcomes.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Before elective surgery, preoperative high-dose glucocorticoids should be weaned to &lt;20 mg per day before surgical intervention if possible as higher doses can increase the risk of postoperative infectious complications [
         <a href="#rid1">
          1
         </a>
         ]. In patients who require emergency surgery, glucocorticoids need to be tapered gradually after surgery. (See
         <a class="medical medical_review" href="/z/d/html/146.html" rel="external">
          "The management of the surgical patient taking glucocorticoids"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7983.html" rel="external">
          "Glucocorticoid withdrawal"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Most immunomodulators (eg,
         <a class="drug drug_general" data-topicid="9612" href="/z/d/drug information/9612.html" rel="external">
          6-mercaptopurine
         </a>
         or
         <a class="drug drug_general" data-topicid="9026" href="/z/d/drug information/9026.html" rel="external">
          azathioprine
         </a>
         ) can be continued until surgery without negative sequelae (eg, postoperative infectious complications) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The impact of preoperative biologic agents upon surgical outcomes has been controversial [
         <a href="#rid4">
          4
         </a>
         ]. In some studies, preoperative use of
         <a class="drug drug_general" data-topicid="8984" href="/z/d/drug information/8984.html" rel="external">
          infliximab
         </a>
         did not increase postoperative complication rates [
         <a href="#rid5">
          5-10
         </a>
         ]. Some other studies have suggested negative effects of newer biologic agents such as
         <a class="drug drug_general" data-topicid="95501" href="/z/d/drug information/95501.html" rel="external">
          vedolizumab
         </a>
         [
         <a href="#rid11">
          11
         </a>
         ] but not
         <a class="drug drug_general" data-topicid="9514" href="/z/d/drug information/9514.html" rel="external">
          ustekinumab
         </a>
         [
         <a href="#rid12">
          12
         </a>
         ]. In other studies, patients who received glucocorticoids or infliximab preoperatively had more postoperative complications and unplanned readmissions [
         <a href="#rid13">
          13-16
         </a>
         ]. There is also evidence that higher preoperative serum levels of biologic agents correlate with worse surgical outcomes [
         <a href="#rid14">
          14
         </a>
         ]. The PUCCINI trial showed that the rates of overall infectious complications or surgical site infections did not differ between patients and controls with previous exposure to anti-tumor necrosis factor agents or detectable serum levels of the drugs [
         <a href="#rid17">
          17
         </a>
         ]. Thus, it appears safe to proceed with elective surgery in patients on biologic therapy when otherwise appropriately medically optimized.
        </p>
        <p>
        </p>
        <p>
         Specific complications related to immunosuppressive drug and biologic agent use are summarized in this table  (
         <a class="graphic graphic_table graphicRef69570" href="/z/d/graphic/69570.html" rel="external">
          table 1
         </a>
         ) and discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4056.html" rel="external">
          "Overview of azathioprine and mercaptopurine use in inflammatory bowel disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3392831907">
         <span class="h2">
          Abdominal imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Abdominal imaging studies are essential in determining the anatomical distribution and complexities of Crohn disease. Both computed tomography enterography (CTE) and magnetic resonance enterography (MRE) are highly accurate in assessing lesions and complications (eg, abscess, fistula) of Crohn disease [
         <a href="#rid18">
          18-21
         </a>
         ]. MRE has the added benefit of not requiring radiation [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14613.html" rel="external">
          "Radiation-related risks of imaging", section on 'Estimating risk from radiation exposure'
         </a>
         .)
        </p>
        <p>
         One important distinction that must be made in patients with stricturing Crohn disease is whether the disease is primarily inflammatory, fibrostenotic, or both. An inflammatory stricture or bowel obstruction is usually characterized by surrounding inflammation on imaging studies. A fibrostenotic stricture or obstruction lacks such inflammation but often has bowel dilation upstream of or in between strictured segments (pseudosacculation) [
         <a href="#rid23">
          23-25
         </a>
         ]. Predominantly inflammatory or fibrostenotic strictures are treated differently as discussed below. (See
         <a class="local">
          'Stricturing diseases'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3886063">
         <span class="h1">
          SURGICAL APPROACHES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Common procedures used to treat Crohn disease of the small bowel, colon, and rectum include bowel resection, strictureplasty, and endoscopic balloon dilatation. (See
         <a class="local">
          'Surgical techniques'
         </a>
         below.)
        </p>
        <p>
         The choice of procedures depends upon the indication for operative intervention and the location(s) of the disease (small bowel versus colorectal).
        </p>
        <p class="headingAnchor" id="H4015777838">
         <span class="h2">
          Penetrating diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 4 to 23 percent of Crohn patients present with a penetrating phenotype characterized by perforation, abscess, or fistulization [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H60220165">
         <span class="h3">
          Perforation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Emergency surgery is required to control sepsis or peritonitis resulting from a bowel perforation. In 1 to 16 percent of patients undergoing surgery for Crohn disease, bowel perforation was the main indication [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
         Patients with a free perforation of the small bowel or colon should undergo immediate surgical resection of the perforated segment. Patients who are hemodynamically unstable or who have edematous bowels, significant intra-abdominal contamination from the perforation, or other risk factors (eg, malnutrition or chronic glucocorticoid use) should have a diverting stoma rather than a primary anastomosis. Stable patients without the above risk factors may undergo primary bowel anastomosis. (See
         <a class="local">
          'Small bowel or ileocecal resection'
         </a>
         below and
         <a class="local">
          'Colorectal resection'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4011010630">
         <span class="h3">
          Abscess
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with an intra-abdominal abscess resulting from Crohn disease should receive antibiotic treatment (see
         <a class="medical medical_review" href="/z/d/html/101694.html" rel="external">
          "Antimicrobial approach to intra-abdominal infections in adults", section on 'Approach to empiric antibiotic selection'
         </a>
         ) and either percutaneous or surgical drainage of the abscess, followed by surgical resection of the involved bowel segment.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Percutaneous drainage
         </strong>
         – Percutaneous drainage is the preferred treatment for intra-abdominal abscesses [
         <a href="#rid28">
          28
         </a>
         ]. Percutaneous drainage can be performed transgluteally or transabdominally depending upon the location of the abscess. It may be repeated as necessary for any residual or recurrent collections. In contemporary practice, approximately 70 percent of Crohn-related abscesses are managed with percutaneous drainage [
         <a href="#rid29">
          29-31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Successful percutaneous drainage of the abscess resolves the intra-abdominal sepsis, after which the involved bowel segment can be resected in a clean rather than contaminated operation. Percutaneous drainage also permits the patient's nutritional status to be improved prior to surgery and decreases their glucocorticoid use perioperatively.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Following the resolution of an intra-abdominal abscess, the involved bowel segment is typically resected, or else at least 30 percent of patients will develop recurrent abscesses or other symptoms. Patients with long-segment disease, however, may be managed medically [
         <a href="#rid32">
          32
         </a>
         ] to avoid postsurgical complications such as diarrhea or even short bowel syndrome.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The optimal timing of bowel resection should be determined individually for each patient. Most surgeons wait five to seven days after a successful percutaneous drainage before operating to allow local sepsis associated with the abscess to resolve [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Abdominal wall abscesses involving the rectus sheath and retroperitoneal abscesses involving the psoas muscle are less common but more difficult to control than intra-abdominal abscesses. In a retrospective review, all 13 abdominal wall abscesses eventually required surgical drainage after multiple failed attempts of percutaneous drainage [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Surgical drainage
         </strong>
         –
         <strong>
         </strong>
         A surgical drainage procedure is performed if percutaneous drainage is not feasible or fails to control the sepsis. For those undergoing surgical drainage of an abscess, whether to perform a concomitant bowel resection is determined by operative findings and the patient's condition [
         <a href="#rid28">
          28
         </a>
         ]. Patients who are dependent on glucocorticoids preoperatively should not undergo concomitant bowel resection with abscess drainage, because of the high risk of anastomotic complications. In a retrospective review of 173 patients undergoing ileocecal or ileocolic resection for Crohn disease, preoperative glucocorticoid use (odds ratio [OR] 2.67, 95% CI 1.0-7.2) and intra-abdominal abscess (OR 3.4, 95% CI 1.2-9.8) were two independent predictors of anastomotic complications [
         <a href="#rid34">
          34
         </a>
         ]. Patients with both risk factors developed significantly more anastomotic complications than those who only had an abscess (40 versus 14 percent). As preoperative use of biologic agents (eg,
         <a class="drug drug_general" data-topicid="8984" href="/z/d/drug information/8984.html" rel="external">
          infliximab
         </a>
         ) has not been shown to negatively impact postoperative outcomes [
         <a href="#rid17">
          17
         </a>
         ], intraoperative decision making should not be significantly influenced by the presence of biologic agent therapy. (See
         <a class="local">
          'Immunosuppressive or biologic therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2869177248">
         <span class="h3">
          Fistula
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transmural bowel inflammation is associated with the development of sinus tracts. Sinus tracts that penetrate the serosa can give rise to fistulas. About 15 percent of patients with Crohn disease develop enteric fistulas [
         <a href="#rid35">
          35
         </a>
         ], which most often connect the intestine to the bladder (enterovesical), skin (enterocutaneous), bowel (enteroenteric), or vagina (enterovaginal). (See
         <a class="medical medical_review" href="/z/d/html/16224.html" rel="external">
          "Medical management of moderate to severe Crohn disease in adults", section on 'Fistulizing disease'
         </a>
         .)
        </p>
        <p>
         Although biologic agents are effective against fistulizing Crohn disease in about half of patients [
         <a href="#rid36">
          36,37
         </a>
         ], refractory fistulas require resection of the involved bowel segment and oversewing of the fistulous opening into the adjacent organ. Resection of the adjacent organ is not necessary unless that organ is also affected by Crohn disease. Intestinal bypass should be avoided because persistent disease in the bypassed segment can lead to complications such as abscess formation, bleeding, perforation, bacterial overgrowth, or malignancy.
        </p>
        <p>
         Crohn disease also causes perianal fistulas, which are treated differently from enteric fistulas. Perianal fistulas related to Crohn disease are discussed in another topic. (See
         <a class="medical medical_review" href="/z/d/html/4082.html" rel="external">
          "Perianal Crohn disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H150648706">
         <span class="h2">
          Stricturing diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         The transmural inflammatory process that characterizes Crohn disease often results in fibrotic strictures that can lead to bowel obstruction. Although the stricturing phenotype is only seen in 5 to 24 percent of Crohn patients [
         <a href="#rid26">
          26
         </a>
         ], it is most responsible for the development of short gut [
         <a href="#rid38">
          38
         </a>
         ]. Hence, the concept of bowel-preserving surgery is most applicable to diffuse stricturing Crohn disease [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         Strictures in Crohn patients can be inflammatory, fibrostenotic, or both. It is paramount to distinguish them by imaging (see
         <a class="local">
          'Abdominal imaging'
         </a>
         above) since treatments are very different: inflammatory strictures are primarily treated medically (see
         <a class="medical medical_review" href="/z/d/html/16224.html" rel="external">
          "Medical management of moderate to severe Crohn disease in adults"
         </a>
         ), whereas fibrostenotic strictures are treated with endoscopic dilation or surgically.
        </p>
        <p class="headingAnchor" id="H3025274954">
         <span class="h3">
          Small bowel stricture
         </span>
         <span class="headingEndMark">
          —
         </span>
         Small bowel strictures respond to endoscopic dilatation, strictureplasty, or surgical resection. The best approach is chosen based upon a stricture's length and complexity as well as the patient's intestinal reserve  (
         <a class="graphic graphic_algorithm graphicRef140078" href="/z/d/graphic/140078.html" rel="external">
          algorithm 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symptomatic, short-segment (&lt;5 cm) small bowel or anastomotic strictures that are not associated with any inflammation or penetrating disease can be treated with surgery or endoscopic dilatation, provided that the location of the stricture is accessible to endoscopic intervention. (See
         <a class="local">
          'Endoscopic dilatation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Longer (≥5 cm), multifocal, complicated strictures and strictures that have failed endoscopic therapy require surgical treatment [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bowel resection can be performed to resect a single stricture or multiple strictures within a short segment of the bowel, especially during the index surgery when the bowel length is otherwise normal. Bowel resection is also performed when strictureplasty is contraindicated (eg, perforation, abscess, fistula, malignancy, severe malnutrition). (See
         <a class="local">
          'Small bowel or ileocecal resection'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Strictureplasty is preferred in patients with diffuse or recurrent strictures in the duodenum, jejunoileum, or neoterminal ileum (after ileocecal resection), especially in those with existing or impending short bowel syndrome. Strictureplasty is contraindicated in the presence of an inflammatory mass, thick and unyielding bowel wall, malignancy, active bleeding, or severe malnutrition [
         <a href="#rid1">
          1,38,39
         </a>
         ]. (See
         <a class="local">
          'Small bowel strictureplasty'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Heineke-Mikulicz strictureplasty  (
         <a class="graphic graphic_figure graphicRef86431" href="/z/d/graphic/86431.html" rel="external">
          figure 1
         </a>
         ) can be performed for strictures up to 10 cm in length (typically 5 to 6 cm).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Finney strictureplasty can be performed for strictures 10 to 20 or 25 cm in length (typically 10 to 12 cm).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Side-to-side isoperistaltic strictureplasty (SSIS)  (
         <a class="graphic graphic_figure graphicRef109472" href="/z/d/graphic/109472.html" rel="external">
          figure 2
         </a>
         ) can be performed for strictures &gt;20 to 25 cm in length.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3482169646">
         <span class="h3">
          Colorectal stricture
         </span>
         <span class="headingEndMark">
          —
         </span>
         Colonic strictures occur in 9 to 13 percent of patients with Crohn disease. They typically occur at a single site and can be associated with dysplasia or cancer in 2 to 6 percent of cases [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="local">
          'Malignancy'
         </a>
         below.)
        </p>
        <p>
         Colorectal strictures that are associated with an anastomosis are typically treated with endoscopic dilatation (see
         <a class="local">
          'Endoscopic dilatation'
         </a>
         below). Other Crohn-related colorectal strictures should be assessed endoscopically with biopsy or brushing; strictures that do not permit endoscopic surveillance are surgically resected [
         <a href="#rid41">
          41
         </a>
         ]. Strictureplasty is not usually performed for colorectal strictures [
         <a href="#rid42">
          42
         </a>
         ]. (See
         <a class="local">
          'Colorectal resection'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H354003990">
         <span class="h2">
          Malignancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Longstanding chronic inflammation associated with Crohn disease can cause intestinal mucosa to undergo malignant transformation. Suspicion of a malignant stricture or fistula in patients with Crohn disease should prompt a resection of the bowel segment including the lesion instead of a strictureplasty or intestinal bypass. (See
         <a class="local">
          'Small bowel or ileocecal resection'
         </a>
         below and
         <a class="local">
          'Small bowel strictureplasty'
         </a>
         below.)
        </p>
        <p>
         Patients with Crohn disease are more likely to develop malignant or premalignant lesions of the colon or rectum than of the small bowel. Such lesions include cancer, high-grade dysplasia, and multifocal low-grade dysplasia. Patients with longstanding Crohn disease should undergo regular colonoscopic surveillance starting no later than eight years from the onset of symptoms [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
         The current management of Crohn patients with diagnosed colonic malignancy is as follows [
         <a href="#rid1">
          1
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/4079.html" rel="external">
          "Surveillance and management of dysplasia in patients with inflammatory bowel disease"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with visible dysplasia may undergo endoscopic resection and continued endoscopic surveillance. However, if the lesion is endoscopically unresectable, multifocal, or found in surrounding flat mucosa, total colectomy or proctocolectomy is indicated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with invisible dysplasia on random biopsy should be referred for high-resolution colonoscopy and chromoendoscopy. If repeat biopsy again shows invisible dysplasia, total colectomy or proctocolectomy is indicated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients diagnosed with adenocarcinoma of the colon should undergo a total colectomy or proctocolectomy.
        </p>
        <p>
        </p>
        <p>
         The choice between total colectomy and proctocolectomy depends on whether there is rectal involvement or rectal sparing of the disease. (See
         <a class="local">
          'Colorectal resection'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4028576820">
         <span class="h2">
          Hemorrhage
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with Crohn disease often have guaiac-positive stools, but acute lower gastrointestinal bleed, which is typically from ulcerative colitis, is unusual and occurs in 1 to 10 percent of patients [
         <a href="#rid44">
          44
         </a>
         ]. Hemodynamically stable patients with significant gastrointestinal bleeding from Crohn disease may be managed endoscopically or angiographically.
        </p>
        <p>
         Unstable patients require urgent bowel resection. if the source of bleeding can be localized by imaging or intraoperative measures, a targeted resection is performed [
         <a href="#rid45">
          45
         </a>
         ]. In cases of persistent hemodynamic instability or serious bleeding that cannot be localized to one segment of the colon, a total
        </p>
        <p>
         colectomy may be necessary [
         <a href="#rid46">
          46
         </a>
         ]. (See
         <a class="local">
          'Colorectal resection'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H746690605">
         <span class="h2">
          Inflammation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 56 to 81 percent of Crohn patients present with an inflammatory phenotype [
         <a href="#rid26">
          26
         </a>
         ], which is most often treated medically. However, such patients may require operative intervention if they do not respond to, develop complications from, or are noncompliant with medical therapy. (See
         <a class="medical medical_review" href="/z/d/html/16224.html" rel="external">
          "Medical management of moderate to severe Crohn disease in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3724156062">
         <span class="h3">
          Small bowel disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with medically refractory Crohn enteritis typically require small bowel resection because strictureplasty and endoscopic dilation are contraindicated in the presence of active inflammation. (See
         <a class="local">
          'Small bowel or ileocecal resection'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2021591163">
         <span class="h3">
          Colorectal disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients who develop acute fulminant colitis or toxic megacolon due to Crohn disease require urgent surgery to prevent sepsis, perforation, or death. A total colectomy with end ileostomy is the procedure of choice in this life-threatening situation. (See
         <a class="medical medical_review" href="/z/d/html/1381.html" rel="external">
          "Toxic megacolon", section on 'Etiology-specific therapy'
         </a>
         .)
        </p>
        <p>
         The surgical management of Crohn colitis or proctitis with a less acute presentation depends upon the location of the disease:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with Crohn colitis, both segmental colectomy and total colectomy with ileorectal anastomosis are effective treatments. The choice depends upon the focality of the disease. (See
         <a class="local">
          'Colectomy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with Crohn disease confined to the anorectum and the perineum, a complete proctectomy with an intersphincteric approach is the surgical treatment of choice. (See
         <a class="local">
          'Proctectomy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with Crohn disease involving both the colon and rectum, a total proctocolectomy with end ileostomy is required. A restorative procedure, such as the ileal pouch-anal anastomosis (IPAA), may be offered [
         <a href="#rid1">
          1
         </a>
         ]. However, performing IPAA for known Crohn disease remains controversial. (See
         <a class="local">
          'Proctocolectomy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1795561719">
         <span class="h2">
          Growth retardation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Crohn disease starts during childhood or adolescence in up to 20 percent of patients, 10 to 40 percent of whom have growth impairment due to chronic intestinal inflammation. Prepubertal patients with Crohn disease require surgery, most commonly bowel resection, if they have growth retardation despite medical therapy [
         <a href="#rid47">
          47
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5893.html" rel="external">
          "Growth failure and pubertal delay in children with inflammatory bowel disease"
         </a>
         and
         <a class="local">
          'Small bowel or ileocecal resection'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1951122237">
         <span class="h1">
          SURGICAL TECHNIQUES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Common procedures used to treat Crohn disease of the small bowel, colon, and rectum include bowel resection, strictureplasty, and endoscopic balloon dilatation. The indications for each procedure have been described above (see
         <a class="local">
          'Surgical approaches'
         </a>
         above); technical details are discussed in this section.
        </p>
        <p class="headingAnchor" id="H4273876874">
         <span class="h2">
          Endoscopic dilatation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Small bowel or anastomotic strictures can be dilated endoscopically with a hydrostatic balloon in select patients who wish to avoid surgery (eg, patients maintained on
         <a class="drug drug_general" data-topicid="8984" href="/z/d/drug information/8984.html" rel="external">
          infliximab
         </a>
         who develop high-grade strictures) or those with a short length of remaining small bowel after prior surgery, provided that the strictures are amenable to endoscopic intervention [
         <a href="#rid48">
          48,49
         </a>
         ].
        </p>
        <p>
         In two meta-analyses, balloon dilatation was technically successful in 86 to 91 percent of patients and clinically successful (relieved symptoms) in 58 to 70 percent of patients [
         <a href="#rid50">
          50,51
         </a>
         ]. Two to three percent of patients developed perforation after balloon dilatation. At three and five years, 42 and 75 percent of patients required surgery for recurrent diseases.
        </p>
        <p>
         Balloon dilatation is more likely to achieve long-term success for short strictures (defined as ≤4 cm [
         <a href="#rid50">
          50
         </a>
         ] or ≤2 cm [
         <a href="#rid52">
          52
         </a>
         ]). Neither active disease at the time of dilatation nor medical therapy afterward predicts the need for repeat dilatation or surgery after balloon dilatation [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         Patients who require salvage surgery after an unsuccessful balloon dilatation may have more complications compared with those who had surgery as the initial treatment. In a prospective, nonrandomized study of ileocolonic strictures due to recurrent Crohn disease, 114 patients underwent surgery as their initial therapy; 80 patients had salvage surgery after failed endoscopic balloon dilatation [
         <a href="#rid54">
          54
         </a>
         ]. Compared with patients who had initial surgical therapy, those who had salvage surgery developed more surgical site infections (15 versus 5 percent) and required more ileostomies (16 versus 6 percent), despite the mean stricture length being significantly longer in the initial surgery group (4 versus 11 cm).
        </p>
        <p>
         In small studies, intralesional steroid injection after balloon dilatation has been shown to improve outcomes in children but not adults. In one randomized trial, 29 children with Crohn strictures underwent balloon dilatation with or without intralesional injection of glucocorticoids [
         <a href="#rid55">
          55
         </a>
         ]. Fewer patients who received injections required repeat dilatations (1 in 15 versus 5 in 14 patients) or surgery (0 in 15 versus 4 in 14 patients). However, glucocorticoid injection did not improve outcomes in a pilot trial of adult patients [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H442515003">
         <span class="h2">
          Small bowel or ileocecal resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with short-segment stricturing or fistulizing disease, bowel resection is the most efficient way to restore health and improve quality of life [
         <a href="#rid57">
          57,58
         </a>
         ]. A small bowel resection is performed when a segment of small bowel is inflamed or perforated or when there is an abscess or fistula to an adjacent organ. An ileocecal resection is performed when the terminal ileum is involved with Crohn disease.
        </p>
        <p class="headingAnchor" id="H379061588">
         <span class="h3">
          Margins of resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because Crohn disease often recurs, bowel resection should be performed with the goal of preserving as much bowel as possible. Gross inspection, rather than histopathology, should determine resection margins since microscopic disease at the margins has not been associated with an increased risk of recurrence. The presence of limited aphthous ulcers at the margins does not mandate further resection. When necessary, intraoperative enteroscopy can be used to assess the bowel lumen for stricture or ulcerative disease that may be involved in resection margins [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
         In a 1996 trial of 152 patients undergoing ileocecal resection for Crohn disease, recurrence was not affected by the width of the margin of resection from macroscopically involved bowel (25 percent with 2 cm margins versus 18 percent with 12 cm margins) [
         <a href="#rid60">
          60
         </a>
         ]. Recurrence rates also did not increase when microscopic disease was present at the resection margins.
        </p>
        <p class="headingAnchor" id="H2962829267">
         <span class="h3">
          Anastomotic technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following a bowel resection, the type of anastomosis (eg, side to side or end to end) performed is determined by surgeon preference as one type of anastomosis has not been conclusively shown to be superior to another based on available data [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
         For technical reasons, hand-sewn anastomoses are typically in an end-to-end configuration, whereas stapled anastomoses are in side-to-side configuration. These two most popular techniques have been compared in multiple trials and nonrandomized comparative studies with most, but not all, studies favoring the stapled technique because of fewer morbidities. The 2020 European Crohn's and Colitis Organization guidelines recommend a stapled side-to-side small bowel or ileocolonic anastomosis after a bowel resection [
         <a href="#rid62">
          62
         </a>
         ]. However, we feel that the decision should be left to the operating surgeon as there are clinical scenarios in which a stapled anastomosis is not feasible or ill advised. This is also the American Society of Colorectal Surgeons (ASCRS) position [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         The Kono-S anastomosis is a functional end-to-end anastomosis that is purposefully designed for bowel resection in Crohn patients [
         <a href="#rid63">
          63,64
         </a>
         ]. To perform a Kono-S anastomosis, bowel resection is carried out with GIA staplers placed perpendicular to the mesentery  (
         <a class="graphic graphic_figure graphicRef109473" href="/z/d/graphic/109473.html" rel="external">
          figure 3
         </a>
         ). The bowel stumps are first reinforced with absorbable sutures, then sutured together to create a common support column, a unique feature of this technique. Bowels on both sides of the center support column are then opened longitudinally at the antimesenteric border starting at 1 cm from the support column. The longitudinal incisions are then hand-sewn closed transversely using absorbable sutures in a single-layer manner to complete the anastomosis. In the completed anastomosis, the support column is positioned between the anastomosis and the mesentery. The potential advantage of this anastomotic configuration is the ability to maintain intestinal diameter and thus prevent distortion or stenosis associated with recurrent strictures, which usually start from the mesenteric side of the lumen [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
         In the first trial comparing the Kono-S anastomosis with conventional side-to-side stapled anastomosis in 79 patients with ileocolic Crohn disease, the Kono-S anastomosis resulted in a significant reduction in postoperative endoscopic (22 versus 63 percent at 6 months), clinical (18 versus 30 percent at 24 months), and surgical recurrence rate (0 versus 5 percent at 24 months) [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
         In a systematic review and meta-analysis of nine studies including the trial described above, the Kono-S anastomosis was associated with a lower incidence of endoscopic (25 versus 67 percent) and surgical recurrence (0 to 3.4 percent versus 15 to 24.4 percent) compared with other types of anastomoses. Complications, particularly anastomotic leak rate, were also lower (1.8 versus 9.3 percent) [
         <a href="#rid66">
          66
         </a>
         ]. Despite these provocative data, further validation by other trials is required before the Kono-S technique can be recommended as the preferred anastomotic technique for those with Crohn disease.
        </p>
        <p class="headingAnchor" id="H47889630">
         <span class="h3">
          Mesenteric resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         While the Kono-S technique advocates mesenteric preservation as a key to reducing recurrence, the opposite has been postulated by others that a wider mesenteric resection may preclude diseased mesentery from promoting disease recurrence [
         <a href="#rid67">
          67
         </a>
         ]. However, this remains a theory; two randomized trials are currently ongoing (NCT03769922 and NCT04266600). Thus, the optimal mesenteric resection and anastomotic techniques remain debated, but there is evidence that they may influence recurrence rates [
         <a href="#rid66">
          66,68
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H442515018">
         <span class="h3">
          Laparoscopic versus open approach
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laparoscopic bowel resection has been increasingly used to treat patients with Crohn disease [
         <a href="#rid69">
          69-71
         </a>
         ], including those who develop recurrent disease after open surgery [
         <a href="#rid72">
          72
         </a>
         ]. Compared with open surgery, laparoscopic surgery has the short-term benefits of reduced morbidity, expedited recovery, and lower cost as well as long-term benefits of fewer small bowel obstructions [
         <a href="#rid73">
          73
         </a>
         ] and incisional hernias [
         <a href="#rid70">
          70,74
         </a>
         ]. Thus, a laparoscopic approach to bowel resection is preferred when the appropriate expertise is available.
        </p>
        <p>
         The benefits of laparoscopic Crohn surgery have been demonstrated in several small randomized trials [
         <a href="#rid75">
          75-77
         </a>
         ] and later illustrated by a large retrospective study of 1917 patients who underwent ileocolonic resection for Crohn disease. Compared with patients who had open surgery, those who underwent laparoscopic resection had fewer major (odds ratio [OR] 0.63, 95% CI 0.43-0.91) and minor (OR 0.58, 95% CI 0.41-0.80) complications as well as a shorter hospital stay (by one day) [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         In a series of 301 laparoscopic resections performed for Crohn disease, one-fifth required conversion to open surgery, mostly commonly due to dense adhesions, pelvic sepsis with fistulizing disease, large inflammatory mass, or thickened mesentery [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p>
         The recurrence rate of Crohn disease treated with laparoscopic surgery remains high. In a retrospective study of 89 patients who underwent laparoscopic ileocolonic resection, 61 percent developed recurrence after a median of 13 months (range 1.3 months to 8.7 years) [
         <a href="#rid79">
          79
         </a>
         ]. In another study, the recurrence rate after laparoscopic ileocolic resection for Crohn disease was comparable to that after open surgery [
         <a href="#rid80">
          80
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1803262820">
         <span class="h2">
          Small bowel strictureplasty
         </span>
         <span class="headingEndMark">
          —
         </span>
         Strictureplasty is an alternative to bowel resection for Crohn patients with strictures of the small bowel, especially those who have lost a significant length of small bowel to previous resections [
         <a href="#rid81">
          81
         </a>
         ]. For patients with bowel obstruction secondary to Crohn disease, a strictureplasty can be performed alone or concomitantly with a bowel resection of a different segment [
         <a href="#rid82">
          82,83
         </a>
         ].
        </p>
        <p>
         The safety and efficacy of strictureplasty were best illustrated by a meta-analysis of observational studies that included 1112 patients with Crohn disease who underwent 3259 strictureplasties [
         <a href="#rid84">
          84
         </a>
         ]. The sites of the strictureplasties were in the small bowel (94 percent), previous anastomosis (4 percent), duodenum (1 percent), or colon (1 percent). Septic complications (leak/fistula/abscess) occurred in 4 percent of patients. At five years, the overall recurrence rate was 28 percent, although only 3 percent were at the same sites as previous strictures. Two patients developed adenocarcinoma at the site of a previous strictureplasty.
        </p>
        <p>
         Three types of strictureplasty are performed in contemporary practice [
         <a href="#rid38">
          38,39
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The Heineke-Mikulicz strictureplasty  (
         <a class="graphic graphic_figure graphicRef86431" href="/z/d/graphic/86431.html" rel="external">
          figure 1
         </a>
         ) is performed most often (in about 85 percent of cases requiring a strictureplasty). Each strictured segment is opened longitudinally at the antimesenteric border, and then the enterotomy is closed transversely. Multiple Heineke-Mikulicz strictureplasties can be performed sequentially. The leak rate is about 6 percent, and the recurrence rate is 25 percent at two years, usually away from the original site.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The Finney strictureplasty is performed in about 5 to 10 percent of the cases requiring a strictureplasty. The diseased segment is first opened longitudinally at the antimesenteric border. The bowel is then folded back on itself, and the enterotomy is closed in a side-to-side antiperistaltic manner. There is a 10 percent risk of anastomotic bleeding, and the recurrence rate is &lt;25 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For more extensive strictures or multiple sequential strictures occurring over a long intestinal segment, a side-to-side isoperistaltic strictureplasty (SSIS) should be performed  (
         <a class="graphic graphic_figure graphicRef109472" href="/z/d/graphic/109472.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid85">
          85-89
         </a>
         ]. SSIS is performed in 5 to 10 percent of the cases requiring a strictureplasty. The bowel and mesentery are first divided at the midpoint of the diseased segment to allow the proximal limb to advance to oppose the distal limb. The two limbs are then opened and the enterotomies are closed in a side-to-side, but isoperistaltic, manner.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The efficacy of SSIS was best illustrated in a prospective observational study of 91 patients who underwent SSIS for Crohn-related strictures; 84 patients were followed for at least 5.5 years [
         <a href="#rid90">
          90
         </a>
         ]. Thirty-seven patients developed a recurrence after 55±37 months, of which 24 were at the same site as the strictureplasty. Nine of the recurrent strictures at the same site as the strictureplasty were treated medically; 15 required surgery (13 with re-strictureplasty and 2 requiring excision of the original strictureplasty).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The durability of SSIS was best illustrated in a retrospective series of 60 patients with a median follow-up of 11 years (range 1 month to 25 years), in which 86 percent of patients kept the original strictureplasty [
         <a href="#rid91">
          91
         </a>
         ]. Although 61 percent developed a symptomatic recurrence, half were remedied with a revision or repeat strictureplasty.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1038704594">
         <span class="h2">
          Colorectal resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical procedures commonly used to treat Crohn colitis or proctitis include segmental colectomy, total colectomy with ileorectal anastomosis, total proctocolectomy with end ileostomy, and proctectomy. The choice of procedure depends upon the location of the disease and the indication for surgery. (See
         <a class="local">
          'Surgical approaches'
         </a>
         above.)
        </p>
        <p>
         The same set of procedures is also used to treat ulcerative colitis and is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1375.html" rel="external">
          "Surgical management of ulcerative colitis", section on 'Surgical options'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14995.html" rel="external">
          "Abdominal perineal resection (APR): Open technique", section on 'Open surgical technique'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H51116611">
         <span class="h3">
          Colectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with Crohn disease may undergo a segmental or a total colectomy, depending upon the extent of the disease. A segmental colectomy is adequate for treating isolated Crohn disease of the colon, such as a colonic stricture that precludes endoscopic surveillance [
         <a href="#rid92">
          92
         </a>
         ]. Patients with two or more involved colonic segments should undergo a total colectomy. In a meta-analysis that compared segmental colectomy with total colectomy for colonic Crohn disease, the two procedures were equally effective, although patients developed earlier recurrences after a segmental colectomy than after a total colectomy [
         <a href="#rid93">
          93
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15261.html" rel="external">
          "Overview of colon resection", section on 'Colon resection'
         </a>
         .)
        </p>
        <p>
         Following a total colectomy, an ileorectal anastomosis (IRA) should be performed if the rectum is not involved with Crohn disease [
         <a href="#rid94">
          94,95
         </a>
         ]. Although the probability of clinical recurrence after IRA was 58 and 83 percent at 5 and 10 years, respectively, the probability of rectal preservation at 10 years was as high as 86 percent [
         <a href="#rid96">
          96
         </a>
         ]. About one-half of patients who had an end ileostomy and a defunctionalized rectum after a total colectomy because of rectal diseases required a secondary proctectomy in 6 to 10 years [
         <a href="#rid96">
          96
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1375.html" rel="external">
          "Surgical management of ulcerative colitis", section on 'Total abdominal colectomy with ileorectal anastomosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1634678810">
         <span class="h3">
          Proctectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with refractory proctitis without colonic involvement, a proctectomy can be performed [
         <a href="#rid96">
          96
         </a>
         ]. The entire rectum should be removed because cancer can develop in a rectal remnant [
         <a href="#rid97">
          97
         </a>
         ].
        </p>
        <p>
         In Crohn patients, an intersphincteric dissection with primary closure of the perineal wound, rather than a standard abdominal perineal resection, should be performed to minimize the risk of a nonhealing perineal wound or sexual dysfunction [
         <a href="#rid98">
          98,99
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14995.html" rel="external">
          "Abdominal perineal resection (APR): Open technique"
         </a>
         .)
        </p>
        <p>
         Crohn disease of the rectum should not be confused with perianal Crohn disease, which includes anal fistula, fissure, or abscess. Perianal Crohn disease is treated medically or by nonresectional procedures [
         <a href="#rid100">
          100
         </a>
         ], which are discussed in another topic. (See
         <a class="medical medical_review" href="/z/d/html/4082.html" rel="external">
          "Perianal Crohn disease", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H968551329">
         <span class="h3">
          Proctocolectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A total proctocolectomy with end ileostomy is performed in patients with longstanding Crohn disease, who either have disease involvement of both the colon and rectum or have malignant/premalignant lesions in either the colon or the rectum. Total proctocolectomy in properly selected patients has been associated with low morbidity, low risk of recurrence, and a long interval to recurrence [
         <a href="#rid101">
          101
         </a>
         ]. (See
         <a class="local">
          'Colorectal disease'
         </a>
         above and
         <a class="local">
          'Malignancy'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3886712">
         <span class="h1">
          POSTOPERATIVE MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgery does not cure Crohn disease. In several studies, the endoscopic recurrence rate was as high as 80 percent at one year after surgery; the clinical recurrence rate was 10 to 15 percent per year [
         <a href="#rid102">
          102,103
         </a>
         ]. Thus, patients will require continued medical therapy or at least regular endoscopic surveillance to detect recurrence. This is discussed in another topic. (See
         <a class="medical medical_review" href="/z/d/html/4084.html" rel="external">
          "Management of Crohn disease after surgical resection"
         </a>
         .)
        </p>
        <p>
         Patients with longstanding Crohn disease, especially of the colon or rectum, are susceptible to developing neoplasms either before or after operative intervention. Thus, postsurgical endoscopic surveillance is important for early detection of both recurrent diseases and malignancy [
         <a href="#rid104">
          104,105
         </a>
         ]. Those with dysplasia or malignancy require further surgery (see
         <a class="local">
          'Malignancy'
         </a>
         above). This is also discussed in another topic. (See
         <a class="medical medical_review" href="/z/d/html/4079.html" rel="external">
          "Surveillance and management of dysplasia in patients with inflammatory bowel disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3604678941">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/109856.html" rel="external">
          "Society guideline links: Crohn disease in adults"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/113229.html" rel="external">
          "Society guideline links: Inflammatory bowel disease in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3870922">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications for medical or antibiotic therapy
         </strong>
         – Medical therapy is the mainstay of treatment for most patients with Crohn disease. Operative management is reserved for those who develop complications (eg, perforation, abscess, fistula, hemorrhage, stricture, fistula, or neoplasm) or have persistent symptoms despite best medical management. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Inflammation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with an intra-abdominal abscess should be treated with antibiotics and undergo percutaneous or surgical drainage of the abscess, followed by surgical resection of the involved bowel segment after the resolution of sepsis. Percutaneous drainage is preferred to surgical drainage whenever possible. (See
         <a class="local">
          'Abscess'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications for bowel resection
         </strong>
         – Patients with Crohn disease who have bowel perforation, abscess, hemorrhage, fistula, neoplasm, or severe inflammation refractory to medical therapy and children who have growth retardation require surgical resection of the bowel segment(s). (See
         <a class="local">
          'Perforation'
         </a>
         above and
         <a class="local">
          'Hemorrhage'
         </a>
         above and
         <a class="local">
          'Fistula'
         </a>
         above and
         <a class="local">
          'Malignancy'
         </a>
         above and
         <a class="local">
          'Inflammation'
         </a>
         above and
         <a class="local">
          'Growth retardation'
         </a>
         above and
         <a class="local">
          'Small bowel or ileocecal resection'
         </a>
         above and
         <a class="local">
          'Colorectal resection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Small bowel and ileocecal resection for Crohn disease can be performed open or laparoscopically; we recommend a laparoscopic approach whenever appropriate expertise is available (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). Compared with open surgery, laparoscopic resection is associated with faster recovery, fewer bowel obstructions, and fewer incisional hernias. (See
         <a class="local">
          'Laparoscopic versus open approach'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For all small bowel or ileocecal resections, we suggest gross inspection, rather than histopathology, to determine resection margins (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). A wide or histologically negative margin can reduce intestinal reserve without reducing recurrences.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The anastomotic technique (eg, side-to-side, end-to-end, Kono-S) is determined by clinical scenario and surgeon preference. (See
         <a class="local">
          'Margins of resection'
         </a>
         above and
         <a class="local">
          'Anastomotic technique'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Resection techniques used to treat Crohn colitis or proctitis include segmental colectomy, total colectomy with ileorectal anastomosis, total proctocolectomy with end ileostomy, and proctectomy. The choice depends upon the indication for surgery, the location of the disease, and whether the rectum is involved or spared. (See
         <a class="local">
          'Colorectal resection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications for endoscopic dilation or strictureplasty
         </strong>
         – Patients with a small bowel or anastomotic stricture can be treated with endoscopic dilatation, small bowel strictureplasty, or small bowel resection. The choice depends upon the stricture's length and complexity as well as the patient's intestinal reserve  (
         <a class="graphic graphic_algorithm graphicRef140078" href="/z/d/graphic/140078.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Stricturing diseases'
         </a>
         above and
         <a class="local">
          'Small bowel or ileocecal resection'
         </a>
         above and
         <a class="local">
          'Small bowel strictureplasty'
         </a>
         above and
         <a class="local">
          'Endoscopic dilatation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Endoscopic balloon dilatation is effective against short (&lt;5 cm) small bowel or anastomotic strictures without inflammatory or penetrating disease. (See
         <a class="local">
          'Endoscopic dilatation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Small bowel strictureplasty is an effective treatment for chronic intestinal stricture without active inflammation or complication. It is most commonly used in patients with existing or impending short bowel syndrome. Conventional strictureplasty techniques (eg, Heineke-Mikulicz  (
         <a class="graphic graphic_figure graphicRef86431" href="/z/d/graphic/86431.html" rel="external">
          figure 1
         </a>
         ) or Finney) are used for focal and short strictures; more extensive strictures or multiple sequential strictures occurring over a long intestinal segment require a side-to-side isoperistaltic strictureplasty  (
         <a class="graphic graphic_figure graphicRef109472" href="/z/d/graphic/109472.html" rel="external">
          figure 2
         </a>
         ). (See
         <a class="local">
          'Small bowel strictureplasty'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Anastomotic colorectal strictures can be treated with endoscopic dilatation. Other Crohn-related strictures of the colon or rectum are best treated with surgical resection. Strictureplasty of the colon is rarely performed. (See
         <a class="local">
          'Colorectal stricture'
         </a>
         above and
         <a class="local">
          'Colorectal resection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H408345843">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Jacques Heppell, MD, FRCSC, FASCRS, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Lightner AL, Vogel JD, Carmichael JC, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's Disease. Dis Colon Rectum 2020; 63:1028.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li G, Ren J, Wang G, et al. Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn's disease. Eur J Clin Nutr 2014; 68:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aberra FN, Lewis JD, Hass D, et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003; 125:320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotze PG, Coy CS. The impact of preoperative anti-TNF in surgical and infectious complications of abdominal procedures for Crohn's disease: controversy still persists. Am J Gastroenterol 2014; 109:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subramanian V, Pollok RC, Kang JY, Kumar D. Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators. Br J Surg 2006; 93:793.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colombel JF, Loftus EV Jr, Tremaine WJ, et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99:878.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marchal L, D'Haens G, Van Assche G, et al. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 2004; 19:749.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaertner WB, Decanini A, Mellgren A, et al. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Dis Colon Rectum 2007; 50:1754.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nasir BS, Dozois EJ, Cima RR, et al. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease. J Gastrointest Surg 2010; 14:1859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Myrelid P, Marti-Gallostra M, Ashraf S, et al. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy. Br J Surg 2014; 101:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lightner AL, McKenna NP, Tse CS, et al. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations. Aliment Pharmacol Ther 2018; 47:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lightner AL, McKenna NP, Tse CS, et al. Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease. J Crohns Colitis 2018; 12:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahmed Ali U, Martin ST, Rao AD, Kiran RP. Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease. Dis Colon Rectum 2014; 57:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lau C, Dubinsky M, Melmed G, et al. The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. Ann Surg 2015; 261:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papaconstantinou I, Zeglinas C, Gazouli M, et al. The impact of peri-operative anti-TNF treatment on anastomosis-related complications in Crohn's disease patients. A critical review. J Gastrointest Surg 2014; 18:1216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White EC, Melmed GY, Vasiliauskas E, et al. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease? Dis Colon Rectum 2012; 55:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen BL, Fleshner P, Kane SV, et al. Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery. Gastroenterology 2022; 163:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pozza A, Scarpa M, Lacognata C, et al. Magnetic resonance enterography for Crohn's disease: what the surgeon can take home. J Gastrointest Surg 2011; 15:1689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 2009; 193:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malgras B, Soyer P, Boudiaf M, et al. Accuracy of imaging for predicting operative approach in Crohn's disease. Br J Surg 2012; 99:1011.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology 2009; 251:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qiu Y, Mao R, Chen BL, et al. Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease. Aliment Pharmacol Ther 2014; 40:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allocca M, Fiorino G, Bonifacio C, et al. Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease. Clin Gastroenterol Hepatol 2019; 17:2397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bettenworth D, Bokemeyer A, Baker M, et al. Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut 2019; 68:1115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rieder F, Bettenworth D, Ma C, et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Aliment Pharmacol Ther 2018; 48:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aniwan S, Park SH, Loftus EV Jr. Epidemiology, Natural History, and Risk Stratification of Crohn's Disease. Gastroenterol Clin North Am 2017; 46:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Werbin N, Haddad R, Greenberg R, et al. Free perforation in Crohn's disease. Isr Med Assoc J 2003; 5:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fleshman JW. Pyogenic complications of Crohn's disease, evaluation, and management. J Gastrointest Surg 2008; 12:2160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cellini C, Safar B, Fleshman J. Surgical management of pyogenic complications of Crohn's disease. Inflamm Bowel Dis 2010; 16:512.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neufeld D, Keidar A, Gutman M, Zissin R. Abdominal wall abscesses in patients with Crohn's disease: clinical outcome. J Gastrointest Surg 2006; 10:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xie Y, Zhu W, Li N, Li J. The outcome of initial percutaneous drainage versus surgical drainage for intra-abdominal abscesses in Crohn's disease. Int J Colorectal Dis 2012; 27:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clancy C, Boland T, Deasy J, et al. A Meta-analysis of Percutaneous Drainage Versus Surgery as the Initial Treatment of Crohn's Disease-related Intra-abdominal Abscess. J Crohns Colitis 2016; 10:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poritz LS, Koltun WA. Percutaneous drainage and ileocolectomy for spontaneous intraabdominal abscess in Crohn's disease. J Gastrointest Surg 2007; 11:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tzivanakis A, Singh JC, Guy RJ, et al. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery. Dis Colon Rectum 2012; 55:558.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tjandra D, Garg M, Behrenbruch C, et al. Review article: investigation and management of internal fistulae in Crohn's disease. Aliment Pharmacol Ther 2021; 53:1064.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaimakliotis P, Simillis C, Harbord M, et al. A Systematic Review Assessing Medical Treatment for Rectovaginal and Enterovesical Fistulae in Crohn's Disease. J Clin Gastroenterol 2016; 50:714.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taxonera C, Barreiro-de-Acosta M, Bastida G, et al. Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease. J Crohns Colitis 2016; 10:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michelassi F. Expert Commentary on Bowel-Preserving Surgery for Diffuse Stricturing Crohn's Jejunoileitis. Dis Colon Rectum 2022; 65:1171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duraes LC, Holubar SD. Bowel-Preserving Surgery for Diffuse Stricturing Crohn's Jejunoileitis. Dis Colon Rectum 2022; 65:1167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sonnenberg A, Genta RM. Epithelial Dysplasia and Cancer in IBD Strictures. J Crohns Colitis 2015; 9:769.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fumery M, Pineton de Chambrun G, Stefanescu C, et al. Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures. Clin Gastroenterol Hepatol 2015; 13:1770.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Broering DC, Eisenberger CF, Koch A, et al. Strictureplasty for large bowel stenosis in Crohn's disease: quality of life after surgical therapy. Int J Colorectal Dis 2001; 16:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiran RP, Khoury W, Church JM, et al. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Ann Surg 2010; 252:330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daperno M, Sostegni R, Rocca R. Lower gastrointestinal bleeding in Crohn's disease: how (un-)common is it and how to tackle it? Dig Liver Dis 2012; 44:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Podugu A, Tandon K, Castro FJ. Crohn's disease presenting as acute gastrointestinal hemorrhage. World J Gastroenterol 2016; 22:4073.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raphaeli T, Menon R. Current treatment of lower gastrointestinal hemorrhage. Clin Colon Rectal Surg 2012; 25:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le Q, Melmed G, Dubinsky M, et al. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease. Inflamm Bowel Dis 2013; 19:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhalme M, Sarkar S, Lal S, et al. Endoscopic balloon dilatation of Crohn's disease strictures: results from a large United kingdom series. Inflamm Bowel Dis 2014; 20:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ono Y, Hirai F, Matsui T, et al. Value of concomitant endoscopic balloon dilation for intestinal stricture during long-term infliximab therapy in patients with Crohn's disease. Dig Endosc 2012; 24:432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hassan C, Zullo A, De Francesco V, et al. Systematic review: Endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007; 26:1457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morar PS, Faiz O, Warusavitarne J, et al. Systematic review with meta-analysis: endoscopic balloon dilatation for Crohn's disease strictures. Aliment Pharmacol Ther 2015; 42:1137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andújar X, Loras C, González B, et al. Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry. Surg Endosc 2020; 34:1112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thienpont C, D'Hoore A, Vermeire S, et al. Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy. Gut 2010; 59:320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Stocchi L, Shen B, et al. Salvage surgery after failure of endoscopic balloon dilatation versus surgery first for ileocolonic anastomotic stricture due to recurrent Crohn's disease. Br J Surg 2015; 102:1418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Nardo G, Oliva S, Passariello M, et al. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointest Endosc 2010; 72:1201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           East JE, Brooker JC, Rutter MD, Saunders BP. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures. Clin Gastroenterol Hepatol 2007; 5:1065.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laine L, Hanauer SB. Considerations in the management of steroid-dependent Crohn's disease. Gastroenterology 2003; 125:906.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delaney CP, Kiran RP, Senagore AJ, et al. Quality of life improves within 30 days of surgery for Crohn's disease. J Am Coll Surg 2003; 196:714.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hotokezaka M, Jimi SI, Hidaka H, et al. Role of intraoperative enteroscopy for surgical decision making with Crohn's disease. Surg Endosc 2007; 21:1238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fazio VW, Marchetti F, Church M, et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial. Ann Surg 1996; 224:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michelassi F. Crohn's recurrence after intestinal resection and anastomosis. Dig Dis Sci 2014; 59:1352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adamina M, Bonovas S, Raine T, et al. ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment. J Crohns Colitis 2020; 14:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kono T, Ashida T, Ebisawa Y, et al. A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn's disease. Dis Colon Rectum 2011; 54:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shimada N, Ohge H, Kono T, et al. Surgical Recurrence at Anastomotic Site After Bowel Resection in Crohn's Disease: Comparison of Kono-S and End-to-end Anastomosis. J Gastrointest Surg 2019; 23:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luglio G, Rispo A, Imperatore N, et al. Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease: The SuPREMe-CD Study - A Randomized Clinical Trial. Ann Surg 2020; 272:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alshantti A, Hind D, Hancock L, Brown SR. The role of Kono-S anastomosis and mesenteric resection in reducing recurrence after surgery for Crohn's disease: a systematic review. Colorectal Dis 2021; 23:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coffey CJ, Kiernan MG, Sahebally SM, et al. Inclusion of the Mesentery in Ileocolic Resection for Crohn's Disease is Associated With Reduced Surgical Recurrence. J Crohns Colitis 2018; 12:1139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dalal RS, Mitri J, Goodrick H, Allegretti JR. Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis. Inflamm Bowel Dis 2021; 27:1694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang R, Valerian BT, Lee EC. Laparoscopic approach in patients with recurrent Crohn's disease. Am Surg 2012; 78:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee Y, Fleming FJ, Deeb AP, et al. A laparoscopic approach reduces short-term complications and length of stay following ileocolic resection in Crohn's disease: an analysis of outcomes from the NSQIP database. Colorectal Dis 2012; 14:572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chaudhary B, Glancy D, Dixon AR. Laparoscopic surgery for recurrent ileocolic Crohn's disease is as safe and effective as primary resection. Colorectal Dis 2011; 13:1413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aytac E, Stocchi L, Remzi FH, Kiran RP. Is laparoscopic surgery for recurrent Crohn's disease beneficial in patients with previous primary resection through midline laparotomy? A case-matched study. Surg Endosc 2012; 26:3552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aquina CT, Probst CP, Becerra AZ, et al. Missed Opportunity: Laparoscopic Colorectal Resection Is Associated With Lower Incidence of Small Bowel Obstruction Compared to an Open Approach. Ann Surg 2016; 264:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel SV, Patel SV, Ramagopalan SV, Ott MC. Laparoscopic surgery for Crohn's disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery. BMC Surg 2013; 13:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maartense S, Dunker MS, Slors JF, et al. Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial. Ann Surg 2006; 243:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milsom JW, Hammerhofer KA, Böhm B, et al. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease. Dis Colon Rectum 2001; 44:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stocchi L, Milsom JW, Fazio VW. Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial. Surgery 2008; 144:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mege D, Michelassi F. Laparoscopy in Crohn Disease: Learning Curve and Current Practice. Ann Surg 2020; 271:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malireddy K, Larson DW, Sandborn WJ, et al. Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease. Arch Surg 2010; 145:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lowney JK, Dietz DW, Birnbaum EH, et al. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn's disease compared with conventional surgery? A long-term, follow-up study. Dis Colon Rectum 2006; 49:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hesham W, Kann BR. Strictureplasty. Clin Colon Rectal Surg 2013; 26:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dietz DW, Fazio VW, Laureti S, et al. Strictureplasty in diffuse Crohn's jejunoileitis: safe and durable. Dis Colon Rectum 2002; 45:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bellolio F, Cohen Z, MacRae HM, et al. Strictureplasty in selected Crohn's disease patients results in acceptable long-term outcome. Dis Colon Rectum 2012; 55:864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis. Dis Colon Rectum 2007; 50:1968.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michelassi F, Upadhyay GA. Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease. J Surg Res 2004; 117:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sampietro GM, Cristaldi M, Maconi G, et al. A prospective, longitudinal study of nonconventional strictureplasty in Crohn's disease. J Am Coll Surg 2004; 199:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tonelli F, Fedi M, Paroli GM, Fazi M. Indications and results of side-to-side isoperistaltic strictureplasty in Crohn's disease. Dis Colon Rectum 2004; 47:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michelassi F, Taschieri A, Tonelli F, et al. An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn's disease. Dis Colon Rectum 2007; 50:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ambe R, Campbell L, Cagir B. A comprehensive review of strictureplasty techniques in Crohn's disease: types, indications, comparisons, and safety. J Gastrointest Surg 2012; 16:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fazi M, Giudici F, Luceri C, et al. Long-term Results and Recurrence-Related Risk Factors for Crohn Disease in Patients Undergoing Side-to-Side Isoperistaltic Strictureplasty. JAMA Surg 2016; 151:452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michelassi F, Mege D, Rubin M, Hurst RD. Long-term Results of the Side-to-side Isoperistaltic Strictureplasty in Crohn Disease: 25-year Follow-up and Outcomes. Ann Surg 2020; 272:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morimoto K, Watanabe K, Noguchi A, et al. Clinical impact of ultrathin colonoscopy for Crohn's disease patients with strictures. J Gastroenterol Hepatol 2015; 30 Suppl 1:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tekkis PP, Purkayastha S, Lanitis S, et al. A comparison of segmental vs subtotal/total colectomy for colonic Crohn's disease: a meta-analysis. Colorectal Dis 2006; 8:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis JD, Schoenfeld P, Lichtenstein GR. An evidence-based approach to studies of the natural history of gastrointestinal diseases: recurrence of symptomatic Crohn's disease after surgery. Clin Gastroenterol Hepatol 2003; 1:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernell O, Lapidus A, Hellers G. Recurrence after colectomy in Crohn's colitis. Dis Colon Rectum 2001; 44:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamamoto T, Watanabe T. Surgery for luminal Crohn's disease. World J Gastroenterol 2014; 20:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cirincione E, Gorfine SR, Bauer JJ. Is Hartmann's procedure safe in Crohn's disease? Report of three cases. Dis Colon Rectum 2000; 43:544.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bauer JJ, Gelernt IM, Salk BA, Kreel I. Proctectomy for inflammatory bowel disease. Am J Surg 1986; 151:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeitels JR, Fiddian-Green RG, Dent TL. Intersphincteric proctectomy. Surgery 1984; 96:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis RT, Bleier JI. Surgical treatment of anorectal crohn disease. Clin Colon Rectal Surg 2013; 26:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fichera A, McCormack R, Rubin MA, et al. Long-term outcome of surgically treated Crohn's colitis: a prospective study. Dis Colon Rectum 2005; 48:963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Cruz P, Kamm MA, Prideaux L, et al. Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm Bowel Dis 2012; 18:758.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Avidan B, Sakhnini E, Lahat A, et al. Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion 2005; 72:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leal-Valdivieso C, Marín I, Mañosa M, et al. Should we monitor Crohn's disease patients for postoperative recurrence after permanent ileostomy? Inflamm Bowel Dis 2012; 18:E196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maykel JA, Hagerman G, Mellgren AF, et al. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum 2006; 49:950.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 86198 Version 24.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32692069" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24549026" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12891531" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24402543" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The impact of preoperative anti-TNF in surgical and infectious complications of abdominal procedures for Crohn's disease: controversy still persists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16710880" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15128354" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15043515" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17899271" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20872084" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24615529" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29250800" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29220430" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24819109" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24950263" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The impact of preoperative serum anti-TNFαtherapy levels on early postoperative outcomes in inflammatory bowel disease surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24599780" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The impact of peri-operative anti-TNF treatment on anastomosis-related complications in Crohn's disease patients. A critical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22513435" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35413359" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21796461" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Magnetic resonance enterography for Crohn's disease: what the surgeon can take home.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19542402" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22556137" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Accuracy of imaging for predicting operative approach in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19276325" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24912799" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30995529" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30944110" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29920726" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838409" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Epidemiology, Natural History, and Risk Stratification of Crohn's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12725136" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Free perforation in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18810560" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Pyogenic complications of Crohn's disease, evaluation, and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20049952" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Surgical management of pyogenic complications of Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16504894" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Abdominal wall abscesses in patients with Crohn's disease: clinical outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22052039" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The outcome of initial percutaneous drainage versus surgical drainage for intra-abdominal abscesses in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26512133" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : A Meta-analysis of Percutaneous Drainage Versus Surgery as the Initial Treatment of Crohn's Disease-related Intra-abdominal Abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17390174" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Percutaneous drainage and ileocolectomy for spontaneous intraabdominal abscess in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22513434" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33721351" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Review article: investigation and management of internal fistulae in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27466166" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : A Systematic Review Assessing Medical Treatment for Rectovaginal and Enterovesical Fistulae in Crohn's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26786982" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35960637" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Expert Commentary on Bowel-Preserving Surgery for Diffuse Stricturing Crohn's Jejunoileitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35960638" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Bowel-Preserving Surgery for Diffuse Stricturing Crohn's Jejunoileitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26079724" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Epithelial Dysplasia and Cancer in IBD Strictures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26001338" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11355323" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Strictureplasty for large bowel stenosis in Crohn's disease: quality of life after surgical therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20622662" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22809958" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Lower gastrointestinal bleeding in Crohn's disease: how (un-)common is it and how to tackle it?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27122659" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Crohn's disease presenting as acute gastrointestinal hemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24294124" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Current treatment of lower gastrointestinal hemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22467562" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24374876" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Endoscopic balloon dilatation of Crohn's disease strictures: results from a large United kingdom series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23078435" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Value of concomitant endoscopic balloon dilation for intestinal stricture during long-term infliximab therapy in patients with Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17903236" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Systematic review: Endoscopic dilatation in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26358739" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Systematic review with meta-analysis: endoscopic balloon dilatation for Crohn's disease strictures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31144122" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19840991" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26313750" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Salvage surgery after failure of endoscopic balloon dilatation versus surgery first for ileocolonic anastomotic stricture due to recurrent Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20951986" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17627903" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12949734" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Considerations in the management of steroid-dependent Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12742203" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Quality of life improves within 30 days of surgery for Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17285372" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Role of intraoperative enteroscopy for surgical decision making with Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8857860" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24671451" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Crohn's recurrence after intestinal resection and anastomosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31742338" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21471760" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30353491" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Surgical Recurrence at Anastomotic Site After Bowel Resection in Crohn's Disease: Comparison of Kono-S and End-to-end Anastomosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32675483" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease: The SuPREMe-CD Study - A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32418300" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The role of Kono-S anastomosis and mesenteric resection in reducing recurrence after surgery for Crohn's disease: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29309546" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Inclusion of the Mesentery in Ileocolic Resection for Crohn's Disease is Associated With Reduced Surgical Recurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33988235" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22546134" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Laparoscopic approach in patients with recurrent Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21831174" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : A laparoscopic approach reduces short-term complications and length of stay following ileocolic resection in Crohn's disease: an analysis of outcomes from the NSQIP database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21087388" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Laparoscopic surgery for recurrent ileocolic Crohn's disease is as safe and effective as primary resection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22648125" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Is laparoscopic surgery for recurrent Crohn's disease beneficial in patients with previous primary resection through midline laparotomy? A case-matched study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26421688" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Missed Opportunity: Laparoscopic Colorectal Resection Is Associated With Lower Incidence of Small Bowel Obstruction Compared to an Open Approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23705825" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Laparoscopic surgery for Crohn's disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16432345" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11805557" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18847647" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30080737" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Laparoscopy in Crohn Disease: Learning Curve and Current Practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20083753" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16328612" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn's disease compared with conventional surgery? A long-term, follow-up study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24436654" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Strictureplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12072628" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Strictureplasty in diffuse Crohn's jejunoileitis: safe and durable.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22810471" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Strictureplasty in selected Crohn's disease patients results in acceptable long-term outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17762967" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Safety and efficacy of strictureplasty for Crohn's disease: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15013717" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15217622" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : A prospective, longitudinal study of nonconventional strictureplasty in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14978615" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Indications and results of side-to-side isoperistaltic strictureplasty in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17245614" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21909847" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : A comprehensive review of strictureplasty techniques in Crohn's disease: types, indications, comparisons, and safety.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26720487" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Long-term Results and Recurrence-Related Risk Factors for Crohn Disease in Patients Undergoing Side-to-Side Isoperistaltic Strictureplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30720502" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Long-term Results of the Side-to-side Isoperistaltic Strictureplasty in Crohn Disease: 25-year Follow-up and Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25827807" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Clinical impact of ultrathin colonoscopy for Crohn's disease patients with strictures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16412066" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : A comparison of segmental vs subtotal/total colectomy for colonic Crohn's disease: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15017495" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : An evidence-based approach to studies of the natural history of gastrointestinal diseases: recurrence of symptomatic Crohn's disease after surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11357022" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Recurrence after colectomy in Crohn's colitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24415860" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Surgery for luminal Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10789755" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Is Hartmann's procedure safe in Crohn's disease? Report of three cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3484910" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Proctectomy for inflammatory bowel disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6484805" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Intersphincteric proctectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24436656" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Surgical treatment of anorectal crohn disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15785882" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Long-term outcome of surgically treated Crohn's colitis: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21830279" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Postoperative recurrent luminal Crohn's disease: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16319461" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Risk factors regarding the need for a second operation in patients with Crohn's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21987356" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Should we monitor Crohn's disease patients for postoperative recurrence after permanent ileostomy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16729218" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
